Goldshield Group Limited (Goldshield) is a marketing-led British Pharmaceutical and Consumer Health company.
The company markets its products in more than 50 countries across the globe with primary focus in UK and EU markets. Goldshield has operational base in the UK, USA and India.
Goldshield sells prescription pharmaceuticals, non-prescription medicines, vitamins, minerals and supplements and a wide range of other healthcare products.
Goldshield was delisted in December 2009 a result of a Management Buy Out by Midas Bidco Limited. Prior to this the group was listed on the London Stock Exchange since 1998. Goldshield has grown to its present size with equity funding of only £1.8 million up to 31 March 1998 having commenced trading in 1991.
Goldshield is accredited ‘Investor in People’ and lays significant emphasis on continuous training and development of its employees.
Goldshield’s business is broadly classified into two product groups - Pharmaceuticals and Consumer Health.